Statistics from Altmetric.com
A previously well immunocompetent man in his 60s presented with a 3-month history of subacute altered mental state and seizures. On clinical examination, he was confused but had no focal neurological deficits. Cerebrospinal fluid (CSF) examination showed minimal cells with an elevated protein of 1.1 g/dL. Epstein-Barr virus (EBV) PCR was positive in the CSF but other bacterial, viral serology and CSF cytology were negative. An extensive panel of autoimmune and paraneoplastic encephalitis antibodies tested negative. MRI brain showed multiple brain lesions with an incomplete (open-ring) pattern of enhancement (figure 1). These were hyperintense on T2-weighted images with no restricted diffusion. The patient was treated for ‘tumefactive’ inflammatory-demyelinating pathology with corticosteroids and plasma exchange but there was no improvement in his symptoms. He developed haemophagocytic lymphohistiocytosis and further increase in size of the brain lesions. A brain biopsy revealed extranodal natural killer/T-cell lymphoma (NKTL). Blood EBV titres were markedly elevated at up to 310 000 IU/mL and EBV-encoded RNA was demonstrated in the brain tissue. Unfortunately, he did not respond to immunotherapy treatment with nivolumab and died about 6 weeks after presentation.
As evidenced in this case, we caution against overinterpreting the specificity of the ‘open-ring’ enhancement pattern, with no restricted diffusion, as a sign of inflammatory aetiology.1 2 The lack of response to immunosuppressive treatment and EBV positivity were unusual for an inflammatory disease process and prompted histological confirmation with a brain biopsy. NKTL is a highly aggressive and rare form of non-Hodgkin’s lymphoma associated with EBV infection.3 It occurs more commonly in the Asian population and typically affects the upper aerodigestive tract such as the nasopharynx and sinuses. Central nervous system involvement is extremely rare and often heralds a poor prognosis.4
Extranodal natural killer/T-cell lymphoma is a rare haematological malignancy that is associated with Epstein-Barr virus infection and can present with central nervous system manifestations.
‘Open-ring’ or incomplete ring enhancement should not be deemed diagnostic of ‘tumefactive’ inflammatory pathology; and due considerations should be given to neoplasms.
Patient consent for publication
Correction notice This article has been corrected since published online first. The author's name has been corrected from “Umapathi Thirugnanam” to “Thirugnanam Umapathi”.
Contributors All authors contributed to the conception and design of the manuscript, the drafting and revising of the article. GL agrees to be accountable for the article and ensures that all questions regarding the accuracy or integrity of the article have been investigated and resolved.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.